Positions

Overview

  • Smita Bhatia, MD, MPH joined UAB in 2015 to establish the Institute for Cancer Outcomes and Survivorship. She is the Gay and Bew White Endowed Professor in Pediatric Oncology and serves as Vice Chair for Outcomes in the Dept. of Pediatrics. She also serves as the Associate Director for Outcomes Research at the UAB Comprehensive Cancer Center. Dr. Bhatia completed her training in Blood Banking, Hematology/ Oncology and BMT from the University of Minnesota, where she also received her MPH in Epidemiology. She joined the Dept. of Pediatric Oncology at the City of Hope in 1996. In 2006, she established a new Dept. of Population Sciences at City of Hope, and served as founding chair of the department until 2014. With over 250 peer-reviewed publications and 17,413 citations, an H-INDEX is 70 and an i10-index of 191, she is an internationally renowned leader in cancer survivorship and outcomes research and has been continually funded by the NIH and by the Leukemia Lymphoma Society since 2000. She has also received funding from the Dept. of Defense, St. Baldrick’s Foundation, V Foundation and ASCO. Dr. Bhatia continues to serve on several Study Sections for the NCI. She serves on the scientific advisory board for several cancer centers as well as several T32 Training grants. She has served (or is currently serving) on the editorial boards of multiple journals including the JCO, BBMT and CEBP; she serves as Section Editor for Cancer. She is a past scholar of the Leukemia Lymphoma Society. She was elected to membership to the American Society for Clinical Investigation and to the Association of American Physicians. She is the recipient of the Frank H Oski Lectureship Award from the American Society of Pediatric Hematology Oncology. She recently received the Outstanding Investigator Award from the NCI. She has served on the Pediatric Cancer Working Group for the NCI Cancer “Moonshot” initiative and is currently serving on the NASEM Committee on a National Strategy for Cancer Control in the United States. She is passionate about mentoring junior investigators.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 Late Mortality after Allogeneic BMT in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic Anemia.Biology of Blood and Marrow Transplantation2018
    2018 Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.Cancer2018
    2018 Post-Acute Care among Older Adults with Stage I to III Colorectal Cancer.Journal of the American Geriatrics Society2018
    2018 Unmet social support needs among older adults with cancer.Cancer2018
    2018 Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.JAMA Oncology.  4:e182453. 2018
    2018 Factors associated with physical inactivity in adult breast cancer survivors-A population-based study.Cancer Medicine.  7:6331-6339. 2018
    2018 Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2.Leukemia.  32:2706-2709. 2018
    2018 Risk of cardiovascular disease among Nordic childhood cancer survivors with diabetes mellitus: A report from adult life after childhood cancer in Scandinavia.Cancer.  124:4393-4400. 2018
    2018 Brain dosimetry from locally advanced head and neck cancer radiotherapy: implications for neurocognitive outcomes research.Acta Oncologica.  57:1589-1592. 2018
    2018 Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.Cancer.  124:4231-4240. 2018
    2018 Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based study.Cancer.  124:4221-4230. 2018
    2018 DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study.Genes, Chromosomes and Cancer.  58:52-59. 2018
    2018 Outcomes of febrile events in pediatric patients with sickle cell anemia.Medical and Pediatric Oncology.  65:e27379. 2018
    2018 Planning post-discharge destination for gastrointestinal surgery patients: Room for improvement?American Journal of Surgery.  216:912-918. 2018
    2018 Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2).Biology of Blood and Marrow Transplantation2018
    2018 Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.Cancer Epidemiology, Biomarkers and Prevention.  27:1133-1141. 2018
    2018 End-of-Life Care Intensity in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: A Population-Level Analysis.Journal of Clinical Oncology.  JCO2018780957. 2018
    2018 Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.Journal of the National Comprehensive Cancer Network.  16:1084-1091. 2018
    2018 Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.Oncologist2018
    2018 Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility.Nature Communications.  9:3184. 2018
    2018 A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy.JNCI: Journal of the National Cancer Institute.  110:895-904. 2018
    2018 Second primary malignancy after multiple myeloma-population trends and cause-specific mortality.British Journal of Haematology.  182:513-520. 2018
    2018 Selecting post-acute care settings after abdominal surgery: Are we getting it right?American Journal of Surgery.  216:260-266. 2018
    2018 Surveillance for Late Effects in Childhood Cancer Survivors.Journal of Clinical Oncology.  36:2216-2222. 2018
    2018 Accuracy of a Novel Handheld Wireless Platform for Detection of Cardiac Dysfunction in Anthracycline-Exposed Survivors of Childhood Cancer.Clinical Cancer Research.  24:3119-3125. 2018
    2018 Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report.Blood.  131:2720-2729. 2018
    2018 Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.Cell Reports.  23:3127-3136. 2018
    2018 Multiplex assessment of protein variant abundance by massively parallel sequencing.Nature Genetics.  50:874-882. 2018
    2018 Predicting and Preventing Anthracycline-Related Cardiotoxicity.American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting.  3-12. 2018
    2018 Inpatient utilization and disparities: The last year of life of adolescent and young adult oncology patients in California.Cancer.  124:1819-1827. 2018
    2018 Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays.BMC Genomics.  19:182. 2018
    2018 New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer.Journal of Clinical Oncology.  36:609-616. 2018
    2018 Prevalence of anthracycline-related cardiac dysfunction in long-term survivors of adult-onset lymphoma.Cancer.  124:850-857. 2018
    2018 Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.Journal of Clinical Oncology.  36:463-475. 2018
    2018 Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.Cancer.  124:617-625. 2018
    2018 Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence.Journal of General Internal Medicine.  33:136-138. 2018
    2018 Evidence for Genetic Risk Contributing to Long-Term Adverse Treatment Effects in Childhood Cancer Survivors.Annual Review of Medicine.  69:247-262. 2018
    2017 Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.Journal of Clinical Oncology.  35:3688-3696. 2017
    2017 Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.JNCI: Journal of the National Cancer Institute.  109. 2017
    2017 Human Papillomavirus Vaccination Rates in Young Cancer Survivors.Journal of Clinical Oncology.  35:3582-3590. 2017
    2017 Disparities in the Intensity of End-of-Life Care for Children With Cancer.Pediatrics.  140. 2017
    2017 End-of-Life Intensity for Adolescents and Young Adults With Cancer: A Californian Population-Based Study That Shows Disparities.Journal of Oncology Practice.  13:e770-e781. 2017
    2017 The Minneapolis-Manchester Quality of Life Instrument: reliability and validity of the Adult Form in cancer survivors.Quality of Life Research.  27:321-332. 2017
    2017 How I monitor long-term and late effects after blood or marrow transplantation.Blood.  130:1302-1314. 2017
    2017 Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.Journal of Clinical Oncology.  35:1730-1736. 2017
    2017 Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.Journal of Clinical Oncology.  35:1598-1605. 2017
    2017 Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.Biology of Blood and Marrow Transplantation.  23:700-705. 2017
    2017 Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.Clinical Cancer Research.  23:1852-1861. 2017
    2017 National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.Biology of Blood and Marrow Transplantation.  23:367-378. 2017
    2017 Impact of treatment site on disparities in outcome among adolescent and young adults with Hodgkin lymphoma.Leukemia.  31:1450-1453. 2017
    2017 Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.Cancer Epidemiology, Biomarkers and Prevention.  26:312-320. 2017
    2017 Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.Blood.  129:1919-1926. 2017
    2017 More than skin-deep: is basal cell carcinoma a marker for a cancer-prone phenotype?British Journal of Dermatology.  176:305-306. 2017
    2017 Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes.PLoS ONE.  12:e0171473. 2017
    2016 Optimizing medication adherence in children with cancer.Current Opinion in Pediatrics.  29:41-45. 2016
    2016 Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.BMC Cardiovascular Disorders.  16:187. 2016
    2016 Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.JAMA Oncology.  2:1277-1286. 2016
    2016 National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.Biology of Blood and Marrow Transplantation.  23:10-23. 2016
    2016 Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.Clinical Pharmacology and Therapeutics.  101:373-381. 2016
    2016 Childhood cancer survivorship research in minority populations: A position paper from the Childhood Cancer Survivor Study.Cancer.  122:2426-2439. 2016
    2016 Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.Journal of Clinical Oncology.  34:3440-3450. 2016
    2016 Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients.Journal of Pediatric Oncology Nursing.  33:422-431. 2016
    2016 Chronic condition clusters and functional impairment in older cancer survivors: a population-based study.Journal of Cancer Survivorship.  10:1096-1103. 2016
    2016 Cardiovascular Disease Risk Profiles in Survivors of Adolescent and Young Adult (AYA) Cancer: The Kaiser Permanente AYA Cancer Survivors Study.Journal of Clinical Oncology.  34:1626-1633. 2016
    2016 Racial/Ethnic Differences in Adverse Outcomes Among Childhood Cancer Survivors: The Childhood Cancer Survivor Study.Journal of Clinical Oncology.  34:1634-1643. 2016
    2016 Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.Biology of Blood and Marrow Transplantation.  22:782-795. 2016
    2016 Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study.Journal of Clinical Oncology.  34:1122-1130. 2016
    2016 Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.Journal of Clinical Oncology.  34:910-918. 2016
    2016 Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.International Journal of Epidemiology.  45:728-740. 2016
    2016 CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.Journal of Clinical Oncology.  34:863-870. 2016
    2016 Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.New England Journal of Medicine.  374:833-842. 2016
    2016 Looking back to inform the future: Lesson learned from survivors of childhood cancer.Cancer.  122:678-680. 2016
    2016 ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.ESMO Open.  1:e000097. 2016
    2015 Impact of Tailored Education on Awareness of Personal Risk for Therapy-Related Complications Among Childhood Cancer Survivors.Journal of Clinical Oncology.  33:3887-3893. 2015
    2015 Differential inequality trends over time in survival among U.S. children with acute lymphoblastic leukemia by race/ethnicity, age at diagnosis, and sex.Cancer Epidemiology, Biomarkers and Prevention.  24:1781-1788. 2015
    2015 Impact of care at comprehensive cancer centers on outcome: Results from a population-based study.Cancer.  121:3885-3893. 2015
    2015 Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.British Journal of Haematology.  171:411-416. 2015
    2015 Collaborative Research in Childhood Cancer Survivorship: The Current Landscape.Journal of Clinical Oncology.  33:3055-3064. 2015
    2015 Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.Nature Genetics.  47:1073-1078. 2015
    2015 Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.Journal of Clinical Oncology.  33:2639-2645. 2015
    2015 In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.Mayo Clinic Proceedings.  90:996-1000. 2015
    2015 Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.JNCI: Journal of the National Cancer Institute.  107. 2015
    2015 Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation.British Journal of Haematology.  170:574-583. 2015
    2015 Reduction in late mortality among 5-year survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).Journal of Clinical Oncology.  33:LBA2. 2015
    2015 Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.JAMA Oncology.  1:287-295. 2015
    2015 Long-term pulmonary function in survivors of childhood cancer.Journal of Clinical Oncology.  33:1592-1600. 2015
    2015 Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.Journal of Clinical Oncology.  33:1235-1242. 2015
    2015 Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.Cancer.  121:648-663. 2015
    2015 Late effects of childhood cancer and its treatment.Pediatric Clinics of North America.  62:275-300. 2015
    2015 Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays.PLoS ONE.  10:e0116078. 2015
    2014 Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.Clinical Cancer Research.  20:6314-6323. 2014
    2014 Caring for the long-term survivor after allogeneic stem cell transplantation.Hematology online (ASH).  2014:495-503. 2014
    2014 Childhood cancer survivor care: development of the Passport for Care.Nature Reviews Clinical Oncology.  11:740-750. 2014
    2014 Impact of care at NCI Comprehensive Cancer Centers (NCICCC) on cancer outcome: Results from a population-based study.Journal of Clinical Oncology.  32:188. 2014
    2014 Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.Journal of Clinical Oncology.  32:3249-3256. 2014
    2014 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.Blood.  124:2345-2353. 2014
    2014 Factors associated with recruiting adult survivors of childhood cancer into clinic-based research.Medical and Pediatric Oncology.  61:1846-1851. 2014
    2014 Parent-directed intervention for children with cancer-related neurobehavioral late effects: a randomized pilot study.Journal of Pediatric Psychology.  39:1013-1027. 2014
    2014 Impact of treatment site in adolescents and young adults with central nervous system tumors.JNCI: Journal of the National Cancer Institute.  106:dju166. 2014
    2014 Breast cancer after chest radiation therapy for childhood cancer.Journal of Clinical Oncology.  32:2217-2223. 2014
    2014 Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.Blood.  124:287-295. 2014
    2014 A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.Nature Communications.  5:3856. 2014
    2014 Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines.Cancer Epidemiology, Biomarkers and Prevention.  23:1109-1114. 2014
    2014 Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.Annals of Internal Medicine.  160:672-683. 2014
    2014 Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.Cancer.  120:955-962. 2014
    2014 Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.Journal of Clinical Oncology.  32:647-653. 2014
    2014 Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group.Journal of Clinical Oncology.  32:527-534. 2014
    2014 Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Clinical Cancer Research.  20:904-911. 2014
    2014 Adolescent and young adult oncology, version 2.2014.Journal of the National Comprehensive Cancer Network.  12:21-32. 2014
    2014 Adolescent and young adult oncology, version 2.2014: Featured updates to the NCCN guidelinesJournal of the National Comprehensive Cancer Network.  12:21-32. 2014
    2014 Granulocytes affect double-strand break repair assays in primary human lymphocytes.PLoS ONE.  9:e93185. 2014
    2013 Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation.Blood.  122:3973-3981. 2013
    2013 Cross-cultural adaptation of the korean version of the minneapolis-manchester quality of life instrument-adolescent form.Journal of Korean Medical Science.  28:1788-1795. 2013
    2013 Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Lancet Oncology.  14:e621-e629. 2013
    2013 Therapy-related myelodysplasia and acute myeloid leukemia.Seminars in Oncology.  40:666-675. 2013
    2013 Impact of care at NCI comprehensive cancer centers (NCICCC) on outcomes in children, adolescents, and young adults (AYA) with central nervous system tumors (CNSt).Journal of Clinical Oncology.  31:123. 2013
    2013 Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation.British Journal of Haematology.  163:205-213. 2013
    2013 Neurocognitive and behavioral outcomes in Latino childhood cancer survivors.Medical and Pediatric Oncology.  60:1696-1702. 2013
    2013 Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.Biology of Blood and Marrow Transplantation.  19:1073-1080. 2013
    2013 Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review.Lancet Oncology.  14:e321-e328. 2013
    2013 Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes.Medical and Pediatric Oncology.  60:1063-1068. 2013
    2013 A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Medical and Pediatric Oncology.  60:543-549. 2013
    2013 Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies.Leukemia.  27:1139-1145. 2013
    2013 American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care.Journal of Clinical Oncology.  31:631-640. 2013
    2013 Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma.Biology of Blood and Marrow Transplantation.  19:260-265. 2013
    2013 Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.JNCI: Journal of the National Cancer Institute.  105:85-94. 2013
    2012 Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.Cancer Research.  72:6425-6434. 2012
    2012 Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.Journal of Clinical Oncology.  30:4401-4408. 2012
    2012 Long-term complications of therapeutic exposures in childhood: lessons learned from childhood cancer survivors.Pediatrics.  130:1141-1143. 2012
    2012 The effect of care at NCI comprehensive cancer centers on disparities in outcome in adolescents and young adults (AYAs) with cancer.Journal of Clinical Oncology.  30:217. 2012
    2012 Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.Blood.  120:4505-4512. 2012
    2012 Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristics.Supportive Care in Cancer.  20:2697-2704. 2012
    2012 Reply to C.D. AtkinsJournal of Clinical Oncology.  30:3563-3564. 2012
    2012 Adolescent and young adult oncology. Clinical practice guidelines in oncology.Journal of the National Comprehensive Cancer Network.  10:1112-1150. 2012
    2012 Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.Medical and Pediatric Oncology.  59:52-56. 2012
    2012 Chronic myelogenous leukemia stem and progenitor cells demonstrate chromosomal instability related to repeated breakage-fusion-bridge cycles mediated by increased nonhomologous end joining.Blood.  119:6187-6197. 2012
    2012 New insights into the risk of breast cancer in childhood cancer survivors treated with chest radiation: A report from the Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study.Journal of Clinical Oncology.  30:CRA9513. 2012
    2012 Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.Journal of Clinical Oncology.  30:2094-2101. 2012
    2012 Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.Journal of Clinical Oncology.  30:1415-1421. 2012
    2012 Genetic susceptibility to therapy-related leukemia after Hodgkin lymphoma or non-Hodgkin lymphoma: role of drug metabolism, apoptosis and DNA repair.Blood Cancer Journal.  2:e58. 2012
    2012 National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.Biology of Blood and Marrow Transplantation.  18:334-347. 2012
    2012 Reply to J. Lagro et alJournal of Clinical Oncology.  30:561-562. 2012
    2012 Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study.Bone Marrow Transplantation.  47:283-290. 2012
    2012 A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.Blood.  119:469-475. 2012
    2012 Subsequent malignant neoplasms after hematopoietic cell transplantation.Biology of Blood and Marrow Transplantation.  18:S139-S150. 2012
    2011 Childhood cancer survivorship educational resources in North American pediatric hematology/oncology fellowship training programs: a survey study.Medical and Pediatric Oncology.  57:1186-1190. 2011
    2011 Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.Blood.  118:6023-6029. 2011
    2011 Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.Cancer Cell.  20:591-605. 2011
    2011 Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).Blood.  118:4723-4731. 2011
    2011 NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges.Biology of Blood and Marrow Transplantation.  17:1428-1435. 2011
    2011 NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.Biology of Blood and Marrow Transplantation.  17:1424-1427. 2011
    2011 Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.Cancer Epidemiology, Biomarkers and Prevention.  20:2048-2067. 2011
    2011 Treatment-related changes in neurobehavioral symptoms.Journal of Clinical Oncology.  29:167. 2011
    2011 Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.Journal of Clinical Oncology.  29:3457-3465. 2011
    2011 Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).Blood.  118:1413-1420. 2011
    2011 Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.Expert Review of Hematology.  4:437-452. 2011
    2011 Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.Journal of Clinical Oncology.  29:3056-3064. 2011
    2011 Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.Nature Medicine.  17:941-943. 2011
    2011 A grounded theory of the process of adherence to oral chemotherapy in Hispanic and caucasian children and adolescents with acute lymphoblastic leukemia.Journal of Pediatric Oncology Nursing.  28:203-223. 2011
    2011 Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study.Blood.  117:6315-6318. 2011
    2011 NMR-based metabolomic analysis of the molecular pathogenesis of therapy-related myelodysplasia/acute myeloid leukemia.Journal of Proteome Research.  10:2873-2881. 2011
    2011 Disparities in cancer outcomes: lessons learned from children with cancer.Medical and Pediatric Oncology.  56:994-1002. 2011
    2011 An interaction of race and ethnicity with socioeconomic status in rectal cancer outcomes.Annals of Surgery.  253:647-654. 2011
    2011 Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.Journal of Clinical Oncology.  29:76-82. 2011
    2010 Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Leukemia.  24:2039-2047. 2010
    2010 Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Blood.  116:3129-3139. 2010
    2010 Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Cancer.  116:4152-4159. 2010
    2010 Transitioning childhood cancer survivors to adult-centered healthcare: insights from parents, adolescent, and young adult survivors.PSYCHO-ONCOLOGY.  19:982-990. 2010
    2010 Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.Biology of Blood and Marrow Transplantation.  16:1138-1144. 2010
    2010 Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.Annals of Internal Medicine.  152:444-455. 2010
    2010 Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns.Blood.  115:2508-2519. 2010
    2010 Psychometric evaluation of the Impact of Cancer (IOC-CS) scale for young adult survivors of childhood cancer.Quality of Life Research.  19:207-218. 2010
    2010 Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.Cancer.  116:1367-1377. 2010
    2010 Long-term consequences of hematopoietic stem cell transplantation: current state of the science.Biology of Blood and Marrow Transplantation.  16:S90-S96. 2010
    2010 Race and ethnicity correlate with survival in patients with gastric adenocarcinoma.Annals of Oncology.  21:152-160. 2010
    2009 Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation.Annals of Oncology.  20:2000-2006. 2009
    2009 Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role?Journal of General Internal Medicine.  24 Suppl 2:S395-S400. 2009
    2009 Second primary cancers in survivors of childhood cancer.Lancet.  374:1484-1485. 2009
    2009 Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.Cancer.  115:4127-4135. 2009
    2009 Disparities in gastric cancer outcomes among Asian ethnicities in the USA.Annals of Surgical Oncology.  16:2433-2441. 2009
    2009 Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.Oncologist.  14:883-890. 2009
    2009 Challenges for retrospective cohort studies: A profile of patients who refuse participation or are lost to follow-up.Journal of Clinical Oncology.  27:6615. 2009
    2009 Differential survival after prostate cancer by race: Role of NCI-designated comprehensive cancer centers.Journal of Clinical Oncology.  27:6520. 2009
    2009 Recommendation of adjuvant chemotherapy and trastuzumab in older adults with HER2-positive breast cancer: A survey of oncologists.Journal of Clinical Oncology.  27:9547. 2009
    2009 Late morbidity after successful treatment of children with cancer.Cancer Journal.  15:174-180. 2009
    2009 Long-term follow-up care for pediatric cancer survivors.Pediatrics.  123:906-915. 2009
    2009 Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma.Journal of Clinical Oncology.  27:791-798. 2009
    2009 Screening for late effects in brain tumor survivors.Cancer Treatment and Research.  150:389-409. 2009
    2008 Late congestive heart failure after hematopoietic cell transplantation.Journal of Clinical Oncology.  26:5537-5543. 2008
    2008 Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers.Journal of Clinical Oncology.  26:5386-5392. 2008
    2008 Health care utilization by adult Hispanic long-term survivors of hematopoietic stem cell transplantation: report from the Bone Marrow Transplant Survivor Study.Cancer.  113:2724-2733. 2008
    2008 Cancer survivorship: a pediatric perspective.Oncologist.  13:1181-1192. 2008
    2008 Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.Cancer.  113:2597-2604. 2008
    2008 Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.Cancer.  113:1580-1587. 2008
    2008 Cardiovascular disease after hematopoietic cell transplantation--lessons learned.Haematologica.  93:1132-1136. 2008
    2008 Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities.Cancer Epidemiology, Biomarkers and Prevention.  17:2194-2201. 2008
    2008 Cancer survivorship research: opportunities and future needs for expanding the research base.Cancer Epidemiology, Biomarkers and Prevention.  17:1551-1557. 2008
    2008 Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation.British Journal of Haematology.  142:11-26. 2008
    2008 Successful coordination and execution of nontherapeutic studies in a cooperative group setting: lessons learned from Children's Oncology Group studies.Cancer Epidemiology, Biomarkers and Prevention.  17:1665-1673. 2008
    2008 The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.Pancreas.  37:19-24. 2008
    2008 Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.Cancer.  112:2789-2795. 2008
    2008 Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia.Onkologie.  31:266-269. 2008
    2008 Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study.Cancer.  112:2071-2079. 2008
    2008 Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.Pediatrics.  121:e387-e396. 2008
    2007 Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.Blood.  110:3784-3792. 2007
    2007 Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.Biology of Blood and Marrow Transplantation.  13:1153-1159. 2007
    2007 Second malignancies after allogeneic hematopoietic cell transplantation.Biology of Blood and Marrow Transplantation.  13:1121-1134. 2007
    2007 Assessment of health-related quality of life of adolescent cancer patients using the Minneapolis-Manchester Quality of Life Adolescent Questionnaire.Medical and Pediatric Oncology.  48:678-686. 2007
    2007 Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study.Cancer Epidemiology, Biomarkers and Prevention.  16:834-839. 2007
    2007 Preparing professional staff to care for cancer survivors.Journal of Cancer Survivorship.  1:98-106. 2007
    2007 Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.Blood.  109:1765-1772. 2007
    2007 Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.Blood.  109:46-51. 2007
    2006 Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.Blood.  108:2867-2873. 2006
    2006 Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: A Report from the Childhood Cancer Survivor Study (CCSS).Journal of Clinical Oncology.  24:9004. 2006
    2006 Solid organ second malignant neoplasms among children diagnosed with malignant bone tumors treated on Children Cancer Study Group/Pediatric Oncology Group protocols after 1980.Journal of Clinical Oncology.  24:9007. 2006
    2006 Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.Bone Marrow Transplantation.  37:1023-1029. 2006
    2006 Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.Cancer.  106:1402-1408. 2006
    2006 Long-term follow-up of childhood cancer survivors: future directions for clinical care and research.Medical and Pediatric Oncology.  46:143-148. 2006
    2005 Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study.Blood.  106:4043-4049. 2005
    2005 Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.Journal of Clinical Oncology.  23:6699-6711. 2005
    2005 Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study.Archives of Pediatrics and Adolescent Medicine.  159:706-713. 2005
    2005 Evaluating survivors of pediatric cancer.Cancer Journal.  11:340-354. 2005
    2005 Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.Blood.  105:4215-4222. 2005
    2005 What is the risk of second malignant neoplasms after childhood cancer?Nature Clinical Practice Oncology.  2:182-183. 2005
    2005 Health-related quality of life in young survivors of childhood cancer using the Minneapolis-Manchester Quality of Life-Youth Form.Pediatrics.  115:435-442. 2005
    2005 Reproducibility, fidelity, and discriminant validity of mRNA amplification for microarray analysis from primary hematopoietic cells.Journal of Molecular Diagnostics.  7:48-56. 2005
    2005 Discharge and unscheduled readmissions of adult patients undergoing hematopoietic stem cell transplantation: implications for developing nursing interventions.Oncology Nursing Forum.  32:E1-E8. 2005
    2005 Cancer survivorship--pediatric issues.Hematology online (ASH).  507-515. 2005
    2005 Discharge and unscheduled readmissions of adult patients undergoing hematopoietic stem cell transplantation: implications for developing nursing interventions.Oncology Nursing Forum.  32. 2005
    2005 Evaluating survivors of pediatric cancer.Cancer Journal.  11:340-354. 2005
    2004 Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.Journal of Clinical Oncology.  22:4979-4990. 2004
    2004 Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study.Blood.  104:1898-1906. 2004
    2004 The Minneapolis-Manchester Quality of Life instrument: Reliability and validity of the Youth Form.Journal of Pediatrics.  145:39-46. 2004
    2004 RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.Leukemia.  18:685-692. 2004
    2004 Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia.Current Opinion in Pediatrics.  16:9-14. 2004
    2003 A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.Biology of Blood and Marrow Transplantation.  9:766-771. 2003
    2003 A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers.American Journal of Epidemiology.  158:1108-1113. 2003
    2003 High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.Journal of Clinical Oncology.  21:4386-4394. 2003
    2003 Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.Journal of the American Medical Association.  290:2008-2014. 2003
    2003 Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence.British Journal of Haematology.  122:345-359. 2003
    2003 Late effects among survivors of leukemia during childhood and adolescence.Blood Cells, Molecules and Diseases.  31:84-92. 2003
    2003 Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.Blood.  101:2015-2023. 2003
    2002 The Minneapolis-Manchester Quality of Life instrument: reliability and validity of the Adolescent Form.Journal of Clinical Oncology.  20:4692-4698. 2002
    2002 Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.Blood.  100:1957-1964. 2002
    2002 Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia.Blood.  100:67-71. 2002
    2002 Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.Blood.  99:4257-4264. 2002
    2002 Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia.Blood.  99:2617-2619. 2002
    2002 Second cancers in survivors of childhood cancer.Nature Reviews Cancer.  2:124-132. 2002
    2001 Is there an association between total-body irradiation and secondary acute myelogenous leukemia/myelodysplastic syndrome in patients with relapsed/refractory Hodgkin's disease treated with autologous stem-cell transplantation?Journal of Clinical Oncology.  19:3585-3588. 2001
    2001 Solid cancers after bone marrow transplantation.Journal of Clinical Oncology.  19:464-471. 2001
    2000 Validation of self-reported complications by bone marrow transplantation survivors.Bone Marrow Transplantation.  25:1191-1196. 2000
    2000 Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.Blood.  95:1588-1593. 2000
    1999 Second primary tumors in patients with cutaneous malignant melanoma.Cancer.  86:2014-2020. 1999
    1999 Family history of cancer in children and young adults with colorectal cancerMedical and Pediatric Oncology.  33:470-475. 1999
    1999 Family history of cancer in children and young adults with colorectal cancer.Medical and Pediatric Oncology.  33:470-475. 1999
    1999 Long-term complications following childhood cancer.Indian Pediatrics.  36:975-980. 1999
    1999 Design of peptides with alpha,beta-dehydro-residues: synthesis, and crystal and molecular structure of a 3(10)-helical tetrapeptide Boc-L-Val-deltaPhe-deltaPhe-L-Ile-OCH3.Peptide research.  54:249-255. 1999
    1999 Epidemiology of leukemia and lymphoma.Current Opinion in Hematology.  6:201-204. 1999
    1998 Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies.Bone Marrow Transplantation.  22:87-90. 1998
    1998 Second cancers after pediatric Hodgkin's disease.Journal of Clinical Oncology.  16:2570-2572. 1998
    1998 Family history of cancer and autoimmune disease and risk of leukemia in infancy: a report from the Children's Cancer Group (United States and Canada).Cancer Causes and Control.  9:161-171. 1998
    1997 Family history of patients with breast cancer after treatment of Hodgkin's disease in childhood. Late Effects Study Group.Lancet.  350:888-889. 1997
    1997 Pleuropulmonary blastoma: a clinicopathologic study of 50 cases.Cancer.  80:147-161. 1997
    1997 Epidemiologic study of Langerhans cell histiocytosis in children.Journal of Pediatrics.  130:774-784. 1997
    1997 Langerhans cell histiocytosis: an exploratory epidemiologic study of 177 cases.Medical and Pediatric Oncology.  28:92-97. 1997
    1996 Thyroid abnormalities after therapy for hodgkin's disease in childhoodOncologist.  1:62-67. 1996
    1996 Design of peptides using alpha, beta-dehydro-residues: synthesis, crystal structure and molecular conformation of N-Boc-L-Val-delta Phe-delta Phe-L-Ala-OCH3.Journal of Peptide Science.  2:357-363. 1996
    1996 Late effects of treatment for childhood Hodgkin's disease.New England Journal of Medicine.  335:352-353. 1996
    1996 Malignant neoplasms following bone marrow transplantation.Blood.  87:3633-3639. 1996
    1996 Breast cancer and other second neoplasms after childhood Hodgkin's disease.New England Journal of Medicine.  334:745-751. 1996
    1995 Epidemiology of childhood acute myelogenous leukemia.Journal of Pediatric Hematology/Oncology.  17:94-100. 1995
    1994 Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation.Transfusion.  34:226-232. 1994

    Chapter

    Year Title Altmetric
    2017 Late Complications of Hematologic Diseases and Their Therapies.  1496-1512.e8. 2017
    2017 Multiple primary cancers.  1155-1190. 2017
    2016 Delayed Non-malignant Complications After Hematopoietic Cell Transplantation.  1266-1276. 2016
    2016 Subsequent Malignant Neoplasms After Hematopoietic Cell Transplantation.  1275-1289. 2016
    2015 Cancer survivorship 2015
    2015 Second cancers 2015
    2015 Transplantation-related malignancies 2015
    2015 Second malignancies following treatment for childhood cancer.  353-367. 2015
    2015 Second malignant neoplasms.  209-220. 2015
    2010 Late effects of cancer treatment and quality of life.  1050-1065. 2010
    2009 Secondary Malignancies after Hematopoietic Cell Transplantation.  1638-1652. 2009
    2007 Medical and psychosocial issues in childhood cancer survivors.  77-89. 2007
    2006 Medical and psychosocial issues in childhood cancer survivors.  1801-1813. 2006
    2006 Epidemiology and etiology.  48-66. 2006
    2004 Epidemiology.  57-69. 2004

    Research Overview

  • My research focuses on cancer outcomes, with a special emphasis on the long-term health and well being of cancer survivors across all cancer diagnoses with the overarching goal to reduce the burden of morbidity among cancer survivors. My research portfolio includes the following: i) a study of the burden of morbidity carried by cancer patients across the entire age spectrum; ii) an understanding of etiology and pathogenesis of the long-term complications identified in cancer survivors; iii) development of risk prediction models to identify survivors at the highest risk; and iv) conducting intervention trials to reduce the complications among the cancer survivors. My research has also focused on understanding the causes of disparity in cancer outcomes, with the goal to develop targeted interventions to reduce the disparities.
  • Principal Investigator On

  • Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors  awarded by National Cancer Institute/NIH/DHHS 2018 - 2025
  • Genetics-guided Individualization of Thiopurine Therapy  awarded by St. Jude Children's Research Hospital 2017 - 2021
  • Childhood Cancer Survivor Study  awarded by St. Jude Children's Research Hospital 2016 - 2021
  • The Who and Why of Anthracycline-related Cardiotoxicity in Childhood Cancer Survivors  awarded by Leukemia and Lymphoma Society 2018 - 2021
  • Testicular Effects of Modern Chemotherapy Regimens in Osteosarcoma Survivors  awarded by SEATTLE CHILDREN'S RESEARCH INSTITUTE 2016 - 2021
  • Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy  awarded by Hutchinson (Fred) Cancer Research Center 2017 - 2021
  • Cost-Effective Breast Cancer Screening Strategies in Chest-Irradiated Women  awarded by BECKMAN RESEARCH INSTITUTE (CITY OF HOPE) 2017 - 2020
  • Developmental & Hyperactive Ras SPORE Project 4: Secondary Cancers among NF1 Cancer Survivors  awarded by Indiana University 2015 - 2020
  • ALTE1621, Reducing Risk of Anthracycline-Related Heart Failure after Childhood Cancer  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2017 - 2020
  • Reducing Risk of Anthracycline-Related Heart Failure after Childhood Cancer  awarded by BECKMAN RESEARCH INSTITUTE (CITY OF HOPE) 2015 - 2020
  • (PQB-1) Telomere Maintenance Defects and Thyroid Second Cancer in Childhood Cancer Survivors  awarded by Baylor College of Medicine 2015 - 2019
  • CHOP NCORP Research Base  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2015 - 2019
  • Late Effects After High Risk Neuroblastoma - The LEAHRN Study  awarded by University of Chicago 2016 - 2019
  • Chronic Health Problems in Survivors of Adolescent and Young Adult Cancer  awarded by Kaiser Foundation 2015 - 2019
  • Long-Term Follow-Up Center to Facilitate Survivorship Research Within COG  awarded by CHILDREN'S ONCOLOGY GROUP 2018 - 2019
  • Developing a Network to Utilize Administrative and Clinical Data for Childhood, Adolescent and Young Adult Oncology Survivorship Research  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2017 - 2019
  • Children's Oncology Group Long-Term Follow-Up Guidelines  awarded by CHILDREN'S ONCOLOGY GROUP 2018
  • Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukemia  awarded by National Cancer Institute/NIH/DHHS 2015 - 2018
  • St.Baldrick's Foundation Support: ALTE15N2 Study  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2017 - 2018
  • Long-term Follow-up Center to Facilitate Survivorship Research within COG  awarded by CHILDREN'S ONCOLOGY GROUP 2017 - 2018
  • Bone Marrow Transplant Survivor Study - 2  awarded by Leukemia and Lymphoma Society 2015 - 2017
  • Dexrazoxane and Prevention of Anthracycline Related Cardiotoxicity  awarded by Hutchinson (Fred) Cancer Research Center 2015 - 2017
  • Comprehensive Approach to Improve Medication Adherence in Pediatric ALL  awarded by St. Baldrick's Foundation 2015 - 2017
  • Long-Term Follow-Up Center to Facilitate Survivorship Research within COG  awarded by St. Baldrick's Foundation 2016 - 2017
  • Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk  awarded by National Cancer Institute/NIH/DHHS 2015 - 2017
  • Childhood Cancer Survivor Study  awarded by St. Jude Children's Research Hospital 2015 - 2016
  • Role of Genetic Susceptibility in Therapy-Related Subsequent Malignancies  awarded by National Cancer Institute/NIH/DHHS 2015 - 2016
  • Bone Marrow Transplant Survivor Study-2 (MBMTSS-2)  awarded by Leukemia and Lymphoma Society 2015 - 2016
  • Long-term Follow-up Center to facilitate Survivorship Research within COG  awarded by St. Baldrick's Foundation 2015 - 2016
  • Novel Methods to Detect Gene-Environment Interactions in Treatment-Related Brain Tumors Among Childhood Cancer Survivors  awarded by University of Wisconsin-Milwaukee 2015 - 2016
  • Scientific Leadership NIH National Clinical Trial Network (NCTN) Grant  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2015 - 2016
  • PAAR4Kids -Pharmacogenomics of Anticancer Agents in Research in Children  awarded by St. Jude Children's Research Hospital 2015
  • Investigator On

  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health  awarded by National Cancer Institute/NIH/DHHS 2018 - 2023
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Administrative Core  awarded by National Cancer Institute/NIH/DHHS 2018 - 2023
  • Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study  awarded by National Cancer Institute/NIH/DHHS 2018 - 2023
  • Health Care Utilization and Associated Costs Among Older Cancer Survivors  awarded by American Cancer Society, Inc. 2018 - 2023
  • Enhancing Shared Decision Making in Metastatic Breast Cancer  awarded by American Cancer Society, Inc. 2017 - 2022
  • Cognitive Training Intervention for Patients Undergoing Allogeneic Blood or Marrow Transplantation for Hematologic Malignancies  awarded by Leukemia and Lymphoma Society 2018 - 2021
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2017 - 2021
  • Comprehensive Cancer Center Core Support Grant - Adiministrative Core  awarded by National Cancer Institute/NIH/DHHS 2017 - 2021
  • Project Everychild APEC14B1  awarded by CHILDREN'S ONCOLOGY GROUP 2015 - 2020
  • AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2015 - 2020
  • A Phase 3 Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC # 606869) in the Very High Risk Stratum  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2014 - 2020
  • Integrating Technology to Enhance Patient/Family Education in Pediatric Oncology  awarded by KAUL PEDIATRIC RESEARCH INSTITUTE 2018 - 2020
  • St. Baldrick's Foundation Supplemental Reimbursement  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2018 - 2020
  • Per Case Reimbursement: COG NCORP Research Base  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2017 - 2019
  • Risk Factors for HPV Vaccine Non-Initiation in Young Adult Cancer Survivors  awarded by American Cancer Society, Inc. 2018 - 2019
  • Understanding Outcome Disparities in AYA with ALL  awarded by RALLY FOUNDATION 2018 - 2019
  • Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors  awarded by National Cancer Institute/NIH/DHHS 2015 - 2019
  • AAML 1031 - Bayer  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2017 - 2019
  • COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2018 - 2019
  • A Comprehensive Investigation of Outcome Disparities in Children, Adolescents and Young Adults with Cancer  awarded by KAUL PEDIATRIC RESEARCH INSTITUTE 2016 - 2018
  • Per Case Reimbursement: COG NCORP Research Base  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2014 - 2018
  • Risk Factors for HPV Vaccine Non-Initiation in Young Adult Cancer Survivors  awarded by American Cancer Society, Inc. 2017 - 2018
  • Follow-Up Care and Preventive Service Use Among Survivors of Adolescent and Young Adult Cancer  awarded by Kaiser Permanente 2016 - 2018
  • St. Baldricks Fdn Supplemental Reimbursement  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2012 - 2018
  • Pilot Study of Dissemination and Implementation of a Virtual Acute Care for the Elderly Program on a Gastrointestinal Surgery Unit  awarded by National Institute on Aging/NIH/DHHS 2017 - 2018
  • AHOD1331 A Randomized Phase III Study of Brentuximab Vedotin (IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2016 - 2018
  • Molecular Pathogenesis of Anthracycline-Related Congestive Heart Failure in Childhood Cancer Survivors  awarded by KAUL PEDIATRIC RESEARCH INSTITUTE 2016 - 2018
  • Developmental and HyperActive RAS Tumor SPORE  awarded by Indiana University 2015 - 2017
  • Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2013 - 2017
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2016 - 2017
  • Comprehensive Cancer Center Core Support Grant - Administrative Core  awarded by National Cancer Institute/NIH/DHHS 2016 - 2017
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2015 - 2017
  • CTSU: Phase II Supplemental Payments (N02-CM-62212)  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2012 - 2017
  • City of Hope Lymphoma SPORE (Core C)  awarded by BECKMAN RESEARCH INSTITUTE (CITY OF HOPE) 2015 - 2016
  • City of Hope Lymphoma SPORE (Project 2)  awarded by City of Hope 2015 - 2016
  • BIQSFP-COG AALL1131 11XS189 Per Case Reimbursement  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2012 - 2015
  • COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2014 - 2015
  • Teaching Overview

  • I am passionate about mentoring junior investigators at all levels of training.
  • Education And Training

  • Doctor of Medicine, Foreign University
  • Full Name

  • Smita Bhatia
  • Blazerid

  • sbhatia